Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Brovana Claims Misleading, Side Effects Minimized: FDA Warning Letter November 4, 2013 Martha Garcia Add Your Comments The FDA has issued a warning letter to Sunovion Pharmaceuticals, indicating that claims the drug manufacturer made about its respiratory drug Brovana are misleading and fail to adequately disclose the potential side effects. Brovana brochures and marketing materials make unsubtantiated claims about the medication, according to an FDA warning letter issued October 24. The FDA accuses the company of claiming that Brovana can make users with breathing problems resume living a normal life and that it is more effective than other treatments, both of which the agency has indicated are misleading characterizations. Do You Know about… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Brovana (arformoterol tartrate) is a bronchodilator. It is an inhaled solution used to treat patients with chronic obstructive pulmonary disease (COPD) who may also suffer from chronic bronchitis and emphysema. It works by relaxing muscles in the airways to improve breathing. The FDA warning lists several grievances against the Massachusetts-based company over violations of the Federal Food, Drug, and Cosmetic Act. The claims Sunovion made about Brovana seriously “misbrand” the drug, according to the FDA. “These claims misleadingly overstate the efficacy of Brovana by suggesting that an outcome of treatment with Brovana is the ability for patients to resume their baseline activities of daily living,” the warning letter stated. The FDA also said the Brovana brochures include claims of superiority over other drugs used to treat COPD. The brochures suggest that the drug is more effective than other medications, but this claim has not been backed up with clinical evidence to support it. Sunovion also uses a tagline, “Get back into daily living,” in marketing materials, which the FDA criticizes in the warning letter, noting it overstates the efficacy of the drug. Clinical studies for Brovana reveal treatment with the drug may cause an 11% improvement in breathing for people suffering from COPD. The FDA argues that improvement in no way represents a dramatic change in lifestyle, like the tagline implicates. To say the drugs is safer or more effective than another drug is deceptive and has not been proven, warns the FDA. “We are not aware of any adequate and well-controlled head-to-head studies supporting the implication that Brovana is clinically superior to other COPD therapies,” the FDA stated. In addition, the advertising materials minimize the potential side effects of Brovana, with risk information placed in a single spaced, small font; as opposed to the large-type bold-faced lettering for the tag lines. Potential for Brovana risks include chest pain, back pain, diarrhea, sinusitis, leg cramps, dyspnea, rash, flu syndrome, peripheral edema and lung disorder. Brovana also contains a Boxed Warning, which warns patients against asthma related complications, as Brovana has not been approved for use in patients who also suffer from asthma. The FDA warns Sunovion to stop using the promotional materials in question. Federal officials also request a written response by Nov. 7 indicating whether the company will comply and change the marketing materials accordingly. Tags: Asthma, Brovana, COPD, Inhaler More Lawsuit Stories MDL Judge Orders Paraquat Lawsuit Settlement Update By June 11, 2025 May 16, 2025 Teen Gambling Problems Frequently Start With Online Sportsbook Betting: Study May 16, 2025 Court Outlines Requirements for Depo-Provera Lawsuit Proof of Use, Type of Meningioma Tumor May 15, 2025 1 Comments Barry May 29, 2016 I’ve been doing the brovana over a year and as a result I do not see much change I cannot still walk a hundred yards but yet I can pass a stress test I had 2 heart attacks in the same weekend October 9th & 10th 2015 I don’t know if the drug has something to do with it but now I live with a stent I have to take blood thinners I had 3 herniated disc I can’t do anything about because of the blood thinners this drug had something to do with me having all the chest pains I did and the serious problem I had when I went in the hospital whatever it is it needs to be on it to see if that was the cause of this I believe that all medical manufacturers of drugs put out to the public should have a little bit more consideration for the lives of the people instead of stamping false statements hiding important statements that can cost people their lives or their way of life therefore I’m stating did Pravana has something to do with me having a stent in me with an n in the whole thing with the surgeries I can’t have my surgeries or nothing and the pain and suffering I’m going through with this Lookout I will hire a really good attorney. May God forgive the actions of the person that knows about this before it hits the markets. Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermNameThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES MDL Judge Orders Paraquat Lawsuit Settlement Update By June 11, 2025 (Posted: today) A federal judge has agreed to stay all case-specific discovery deadlines in Paraquat lawsuits, while the parties work to hammer out a settlement agreement to resolve thousands of claims. MORE ABOUT: PARAQUAT PARKINSON’S DISEASE LAWSUITSParaquat Settlement Reached for Parkinson’s Disease Lawsuits Filed in MDL (04/16/2025)Appeals Court Urged To Reinstate Paraquat Lawsuits Previously Set for Bellwether Trials (02/14/2025)Paraquat Lawsuits Over Parkinson’s Disease Risk Set for Trial in October 2025, April 2026 (01/29/2025) Court Outlines Requirements for Depo-Provera Lawsuit Proof of Use, Type of Meningioma Tumor (Posted: yesterday) As new Depo-Provera lawsuits continue to be filed, the judge presiding over the litigation has established key criteria for establishing proof of Depo-Provera use and medical documentation confirming a meningioma diagnosis. MORE ABOUT: DEPO-PROVERA LAWSUITDepo Shot Lawsuit Filed Over Serious Brain Tumor Injuries (05/07/2025)Lawsuit Alleges Depo-Provera Migraines, Headaches Led to Meningioma Brain Tumor Diagnosis (05/01/2025)Depo-Provera Hearing Loss Lawsuit Filed Over Brain Tumor Side Effects (04/22/2025) BioZorb Implant Lawsuit Alleges Tissue Marker Caused Swelling, Fluid Buildup and Chronic Pain (Posted: 2 days ago) A Massachusetts woman’s injuries from a failed tissue marker that was recently recalled led to the need for physical therapy, according to a BioZorb implant lawsuit. MORE ABOUT: BIOZORB LAWSUITFour Women File BioZorb Lawsuit Over Breast Tissue Marker Failures and Injuries (05/05/2025)Lawsuit Claims BioZorb Marker Caused Chronic Pain, Multiple Surgeries After Lumpectomy (04/14/2025)Four BioZorb Breast Tissue Marker Lawsuits Selected for Bellwether Trials (04/02/2025)
Court Outlines Requirements for Depo-Provera Lawsuit Proof of Use, Type of Meningioma Tumor May 15, 2025
MDL Judge Orders Paraquat Lawsuit Settlement Update By June 11, 2025 (Posted: today) A federal judge has agreed to stay all case-specific discovery deadlines in Paraquat lawsuits, while the parties work to hammer out a settlement agreement to resolve thousands of claims. MORE ABOUT: PARAQUAT PARKINSON’S DISEASE LAWSUITSParaquat Settlement Reached for Parkinson’s Disease Lawsuits Filed in MDL (04/16/2025)Appeals Court Urged To Reinstate Paraquat Lawsuits Previously Set for Bellwether Trials (02/14/2025)Paraquat Lawsuits Over Parkinson’s Disease Risk Set for Trial in October 2025, April 2026 (01/29/2025)
Court Outlines Requirements for Depo-Provera Lawsuit Proof of Use, Type of Meningioma Tumor (Posted: yesterday) As new Depo-Provera lawsuits continue to be filed, the judge presiding over the litigation has established key criteria for establishing proof of Depo-Provera use and medical documentation confirming a meningioma diagnosis. MORE ABOUT: DEPO-PROVERA LAWSUITDepo Shot Lawsuit Filed Over Serious Brain Tumor Injuries (05/07/2025)Lawsuit Alleges Depo-Provera Migraines, Headaches Led to Meningioma Brain Tumor Diagnosis (05/01/2025)Depo-Provera Hearing Loss Lawsuit Filed Over Brain Tumor Side Effects (04/22/2025)
BioZorb Implant Lawsuit Alleges Tissue Marker Caused Swelling, Fluid Buildup and Chronic Pain (Posted: 2 days ago) A Massachusetts woman’s injuries from a failed tissue marker that was recently recalled led to the need for physical therapy, according to a BioZorb implant lawsuit. MORE ABOUT: BIOZORB LAWSUITFour Women File BioZorb Lawsuit Over Breast Tissue Marker Failures and Injuries (05/05/2025)Lawsuit Claims BioZorb Marker Caused Chronic Pain, Multiple Surgeries After Lumpectomy (04/14/2025)Four BioZorb Breast Tissue Marker Lawsuits Selected for Bellwether Trials (04/02/2025)